This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West

Savings Deadline Expires:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
March 18-21, 2025
San Diego Convention CenterSan Diego, CA, USA

Dr. Vaibhav Deokar
Principal Scientist at Lupin Limited (Biotech Division)
Speaker

Profile

Dr. Vaibhav Deokar is Principal Scientist at Formulation Development Team of R&D, Lupin Limited (Biotech Division), India. He has pursued M.Tech (Bioprocess Technology) from the Institute of Chemical Technology (ICT) (formerly UDCT), Mumbai and completed his doctoral research under Lupin’s ASCENT PhD program. He has authored research articles in peer reviewed journals and is a key contributor to 7 formulation patents for biopharmaceuticals. He has 15+ years of experience in developing formulations for complex biopharmaceuticals like peptides, fusion proteins, and high concentration antibody formulations. He is responsible for fill-finish process development, characterization and technology transfer within Lupin and other drug product manufacturing facilities. He has faced regulatory agencies for formulation and fill-finish process development related queries. He has special interests in new product development, product differentiation and enhancement strategies and has provided new differentiation strategies for couple of products in pipeline.

Agenda Sessions

  • Challenges and solutions to manufacturing of low viscosity, ultra-high concentration IgG1 drug products: From late downstream process to final fill finish processing.

    2:45pm